We hope you enjoy this excerpt from Litigation Daily, the exclusive source for sharp commentary on mega court battles, winning strategies and the issues that obsess elite litigators. Law.com subscribers can sign up for The AmLaw Litigation Daily newsletter here. Anyone else can click here to subscribe.
My colleague Charles Toutant is up with a fascinating look at how the public perception of pharmaceutical companies changed over the past year and the worries that those changes have sparked among the members of the plaintiffs bar who regularly litigate against drug makers.
